Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07531316 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from Virginia Commonwealth University

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv7
  2. Recruitment opened
    • Start date: Aug 15, 2026 to Aug 28, 2026
    • Site details revised
    v6
  3. Start date: Jul 15, 2026 to Aug 15, 2026v5
  4. Primary endpoint(s) modified
    • Secondary endpoints revised (2)
    v4
  5. Start date: Jun 1, 2026 to Jul 15, 2026v3
  6. Start date: Apr 1, 2026 to Jun 1, 2026
    • Collaborators expanded, about 6 words
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to do follow-up testing on the safety and tolerability of an experimental (not FDA approved) medication. This study is seeking non-illicit drug using adults to test the medication. Results of this study will help us to develop future studies to test the medication with people who use substances. This research is supported by and included in the NIH HEAL Initiative (https://heal.nih.gov/).
Trial Details
NCT Number NCT07531316
Lead Sponsor Virginia Commonwealth University
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions
(from sponsor)		 Healthy Controls
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov